Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Connect with investors, share insights, and grow together
Stay up to date on latest investing trends and other announcements
Explore our range of financial tools to streamline your investment planning
A structured, comprehensive way to understand global investing
Read about our journey and get to know the leadership team at Vested
The fund will invest at least 80% of its net assets (plus borrowings for investment purposes) in instruments in its underlying index or in instruments that have economic characteristics similar to those in the underlying index. The underlying index is a free float adjusted market capitalization weighted index, subject to the 10/40 Constraint, which is designed to measure the equity market performance of Chinese companies in the healthcare sector. The fund is non-diversified. more
| Time Frame | KURE | S&P500 |
|---|---|---|
| 1-Week Return | -3.27% | -2.26% |
| 1-Month Return | -15.3% | -0.27% |
| 3-Month Return | -14.75% | 8.83% |
| 6-Month Return | -21.27% | 7.2% |
| 1-Year Return | -16.16% | 22.24% |
| 3-Year Return | -21.44% | 69.99% |
| 5-Year Return | -67.2% | 74.03% |
| 10-Year Return | -40.44% | 251.74% |
| Time Frame | KURE | S&P500 |
|---|---|---|
| 1-Week Return | -82.33% | -69.64% |
| 1-Month Return | -86.74% | -3.24% |
| 3-Month Return | -47.65% | 40.94% |
| 6-Month Return | -38.43% | 15.14% |
| 1-Year Return | -16.16% | 22.24% |
| 3-Year Return | -7.73% | 19.35% |
| 5-Year Return | -19.98% | 11.72% |
| 10-Year Return | -5.05% | 13.40% |
| Stock name | Ticker | Weight |
|---|---|---|
BEONE MEDICINES LTD-H | 6160.HK | 9.04% |
INNOVENT BIOLOGICS INC | 1801.HK | 8.47% |
WUXI BIOLOGICS CAYMAN INC | 2269.HK | 8.06% |
WUXI APPTEC CO LTD-A | 603259.SS | 5.77% |
SHENZHEN MINDRAY BIO-MEDIC-A | 300760.SZ | 4.44% |
JIANGSU HENGRUI PHARMACEUT-A | 600276.SS | 4.39% |
AKESO INC | 9926.HK | 4.01% |
CSPC PHARMACEUTICAL GROUP LT | 1093.HK | 3.92% |
WUXI APPTEC CO LTD-H | 2359.HK | 3.56% |
SINO BIOPHARMACEUTICAL | 1177.HK | 3.54% |
HANSOH PHARMACEUTICAL GROUP | 3692.HK | 2.8% |
SHANGHAI UNITED IMAGING HE-A | 688271.SS | 2.49% |
YUNNAN BAIYAO GROUP CO LTD-A | 000538.SZ | 2.33% |
3SBIO INC | 1530.HK | 2.3% |
AIER EYE HOSPITAL GROUP CO-A | 300015.SZ | 2.13% |
ZHANGZHOU PIENTZEHUANG PHA-A | 600436.SS | 1.96% |
SINOPHARM GROUP CO-H | 1099.HK | 1.78% |
SICHUAN KELUN-BIOTECH BIOP-H | 6990.HK | 1.68% |
SICHUAN KELUN PHARMACEUTIC-A | 002422.SZ | 1.48% |
SICHUAN BIOKIN PHARMACEUTI-A | . | 1.41% |
LEGEND BIOTECH CORP-ADR | LEGN | 1.4% |
WUXI XDC CAYMAN INC | 2268.HK | 1.34% |
HUADONG MEDICINE CO LTD-A | 000963.SZ | 1.33% |
SHANGHAI FOSUN PHARMACEUTI-A | 600196.SS | 1.25% |
SHANGHAI PHARMACEUTICALS-A | 601607.SS | 1.21% |
GENSCRIPT BIOTECH CORP | 1548.HK | 1.2% |
HAISCO PHARMACEUTICAL GROU-A | 002653.SZ | 1.12% |
CHINA RESOURCES SANJIU MED-A | 000999.SZ | 1.08% |
REMEGEN CO LTD-H | 9995.HK | 1.02% |
SHANGHAI ALLIST PHARMACEUT-A | 688578.SS | 1.01% |
REMEGEN CO LTD-A | 688331.SS | 0.97% |
SHENZHEN SALUBRIS PHARM-A | 002294.SZ | 0.96% |
XTALPI HOLDINGS LTD | 2228.HK | 0.95% |
SHENZHEN NEW INDUSTRIES BI-A | 300832.SZ | 0.93% |
HEBEI CHANGSHAN BIOCHEMICA-A | 300255.SZ | 0.92% |
SHANGHAI RAAS BLOOD PRODUC-A | 002252.SZ | 0.92% |
BEIJING TONG REN TANG CO-A | 600085.SS | 0.92% |
PHARMARON BEIJING CO LTD-A | 300759.SZ | 0.91% |
BEIJING WANTAI BIOLOGICAL-A | 603392.SS | 0.81% |
IMEIK TECHNOLOGY DEVELOPME-A | 300896.SZ | 0.8% |
CHONGQING ZHIFEI BIOLOGICA-A | 300122.SZ | 0.8% |
APT MEDICAL INC-A | 688617.SS | 0.76% |
CHANGCHUN HIGH-TECH INDUST-A | 000661.SZ | 0.75% |
CSPC INNOVATION PHARMACEUT-A | 300765.SZ | 0.68% |
HANGZHOU TIGERMED CONSULTI-A | 300347.SZ | 0.38% |
Cash | . | 0.03% |
GUANGZHOU BAIYUNSHAN PHAR-A | 600332.SS | 0% |
HONG KONG DOLLAR | . | 0% |
KANGMEI PHARMA - RIGHTS O | . | 0% |
| Sector | Weight |
|---|---|
|
Health care | 99.31% |
|
Consumer staples | 0.69% |
KraneShares MSCI All China Health Care Index ETF (KURE) share price today is $14.722.
Yes, Indians can buy shares of KraneShares MSCI All China Health Care Index ETF (KURE) on Vested. To buy KURE from India, you can open a US Brokerage account by signing up on Vested. The account opening process is completely digital and secure, and takes 3-5 minutes to complete.
Yes, you can purchase fractional shares of KraneShares MSCI All China Health Care Index ETF (KURE) on Vested. You can start investing in KraneShares MSCI All China Health Care Index ETF (KURE) with a minimum investment of $1.
The 52-week high price of KraneShares MSCI All China Health Care Index ETF (KURE) is $21.04. The 52-week low price of KraneShares MSCI All China Health Care Index ETF (KURE) is $14.38.
The stock symbol (or ticker) of KraneShares MSCI All China Health Care Index ETF is KURE.
Yes, you can setup SIP in KraneShares MSCI All China Health Care Index ETF shares. Follow the below steps to create the SIP:
Here is the historical performance of KURE on the Vested app.
The expense ratio of KraneShares MSCI All China Health Care Index ETF (KURE) is 0.65%.
Link copied